+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Chronic Refractory Cough Market by Drug Class (Neuromodulators, Opioid Antagonists, P2X3 Antagonists), Route Of Administration (Inhalation, Injectable, Oral), Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Chronic Refractory Cough Market by Drug Class (Neuromodulators, Opioid Antagonists, P2X3 Antagonists), Route Of Administration (Inhalation, Injectable, Oral), Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Chronic Refractory Cough Market by Drug Class (Neuromodulators, Opioid Antagonists, P2X3 Antagonists), Route Of Administration (Inhalation, Injectable, Oral), Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5968261
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The chronic refractory cough market is advancing as next-generation therapies and technologies redefine patient management standards. Heightened awareness of unmet clinical needs is encouraging innovation and strategic investment across the pharmaceutical landscape, presenting new opportunities for growth and competitive positioning.

Market Snapshot: Chronic Refractory Cough Market Overview

The Chronic Refractory Cough Market grew from USD 5.88 billion in 2024 to USD 6.23 billion in 2025. It is expected to continue growing at a CAGR of 5.95%, reaching USD 8.32 billion by 2030. Expansion is underpinned by rising demand for advanced cough therapies, a shift in regulatory landscapes, and increased focus on targeted mechanisms of action for improved clinical outcomes. The market’s progression is also supported by adoption of patient-centric technology solutions and evolving supply chain strategies that enable broader access and enhanced care delivery.

Scope & Segmentation

  • Drug Classes: Neuromodulators, Opioid Antagonists, P2X3 Antagonists.
  • Routes of Administration: Inhalation, Injectable, Oral.
  • Distribution Channels: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies.
  • End Users: Homecare, Hospitals, Specialty Clinics.
  • Geographic Coverage: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Industry Players: Merck & Co., Inc., Bayer AG, Bellus Health Inc., Shionogi & Co., Ltd., Johnson & Johnson, GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG.

Key Takeaways & Strategic Insights

  • Selective targeting of sensory pathways is creating a paradigm shift in chronic refractory cough management, overcoming traditional limitations of established treatments.
  • Emerging technologies—such as wearable monitors and remote patient engagement platforms—streamline clinical trial processes and support greater individualization of therapy regimens.
  • Cross-sector partnerships between biopharmaceutical leaders, digital innovators, and advocacy groups are accelerating real-world evidence generation, adding rigor to regulatory submissions.
  • Regional differences in healthcare capabilities and adoption trends call for localized strategies that address infrastructure gaps, reimbursement dynamics, and patient preferences.
  • Supply chain diversification has become a necessary response to global challenges, emphasizing flexible sourcing, manufacturing proximity, and collaborative contract arrangements.
  • Intellectual property strategies now focus on platform-based and combination approaches, strengthening market access and differentiation potential in a competitive environment.

Tariff Impact on Cost Structures and Supply Dynamics

Recent United States tariffs have altered chronic refractory cough therapy supply chains, increasing input expenses and prompting a strategic reassessment of supplier partnerships. Pharmaceutical organizations are evaluating geographically dispersed manufacturing networks to ensure supply resilience and manage cost fluctuations. These shifts require adjustments in clinical trial budgeting and a greater focus on financial efficiency to maintain competitiveness.

Methodology & Data Sources

This research uses primary interviews with opinion leaders and industry executives, along with in-depth secondary scans of peer-reviewed literature, regulatory filings, and clinical trial registries. Analytical tools such as SWOT analysis and scenario modeling validate conclusions. Rigorous triangulation of all data points underpins the quality of insights provided.

Why This Report Matters

  • Enables informed strategic investment in chronic refractory cough therapies for sustainable market positioning.
  • Supports evidence-driven development and go-to-market planning tailored by region, technology, and end user.
  • Equips industry leaders with actionable insights on supply chain adaptation, regulatory trends, and competitive differentiation.

Conclusion

The chronic refractory cough market is positioned for transformation, driven by mechanistic advances, targeted therapies, and integrated digital solutions. Organizations that prioritize innovation, supply resilience, and strategic collaboration will be best equipped to meet unmet patient needs while capturing future market opportunities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing focus on P2X3 receptor antagonist therapies for refractory chronic cough management
5.2. Increasing investment in digital cough monitoring technologies to enhance patient adherence
5.3. Advancements in neuromodulators targeting vagal nerve pathways for chronic cough symptom relief
5.4. Surge in collaborative partnerships between biotech firms and academic institutions for cough research
5.5. Expansion of over the counter combination therapies addressing cough and comorbid respiratory conditions
5.6. Growing emphasis on real world evidence and patient reported outcomes in chronic cough trials
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Chronic Refractory Cough Market, by Drug Class
8.1. Introduction
8.2. Neuromodulators
8.3. Opioid Antagonists
8.4. P2X3 Antagonists
9. Chronic Refractory Cough Market, by Route Of Administration
9.1. Introduction
9.2. Inhalation
9.3. Injectable
9.4. Oral
10. Chronic Refractory Cough Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Chronic Refractory Cough Market, by End User
11.1. Introduction
11.2. Homecare
11.3. Hospitals
11.4. Specialty Clinics
12. Americas Chronic Refractory Cough Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Chronic Refractory Cough Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Chronic Refractory Cough Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Merck & Co., Inc.
15.3.2. Bayer AG
15.3.3. Bellus Health Inc.
15.3.4. Shionogi & Co., Ltd.
15.3.5. Johnson & Johnson
15.3.6. GlaxoSmithKline plc
15.3.7. Sanofi S.A.
15.3.8. Pfizer Inc.
15.3.9. Teva Pharmaceutical Industries Ltd.
15.3.10. Novartis AG
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CHRONIC REFRACTORY COUGH MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CHRONIC REFRACTORY COUGH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CHRONIC REFRACTORY COUGH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CHRONIC REFRACTORY COUGH MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CHRONIC REFRACTORY COUGH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CHRONIC REFRACTORY COUGH MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CHRONIC REFRACTORY COUGH MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CHRONIC REFRACTORY COUGH MARKET: RESEARCHAI
FIGURE 24. CHRONIC REFRACTORY COUGH MARKET: RESEARCHSTATISTICS
FIGURE 25. CHRONIC REFRACTORY COUGH MARKET: RESEARCHCONTACTS
FIGURE 26. CHRONIC REFRACTORY COUGH MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CHRONIC REFRACTORY COUGH MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY NEUROMODULATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY NEUROMODULATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY OPIOID ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY OPIOID ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY P2X3 ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY P2X3 ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CHRONIC REFRACTORY COUGH MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. AMERICAS CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 42. AMERICAS CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS CHRONIC REFRACTORY COUGH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS CHRONIC REFRACTORY COUGH MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 51. UNITED STATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 52. UNITED STATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 53. UNITED STATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 54. UNITED STATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 61. CANADA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 62. CANADA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 63. CANADA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 64. CANADA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 65. CANADA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. CANADA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. CANADA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. CANADA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. MEXICO CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 70. MEXICO CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 71. MEXICO CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 72. MEXICO CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 73. MEXICO CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. MEXICO CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. MEXICO CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. MEXICO CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. BRAZIL CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 78. BRAZIL CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 79. BRAZIL CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 80. BRAZIL CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 81. BRAZIL CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. BRAZIL CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. BRAZIL CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. BRAZIL CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. ARGENTINA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 86. ARGENTINA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 87. ARGENTINA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 88. ARGENTINA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 89. ARGENTINA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. ARGENTINA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. ARGENTINA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. ARGENTINA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 104. UNITED KINGDOM CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 106. UNITED KINGDOM CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. UNITED KINGDOM CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED KINGDOM CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. GERMANY CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 112. GERMANY CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 113. GERMANY CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. GERMANY CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. GERMANY CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. GERMANY CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. GERMANY CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. GERMANY CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. FRANCE CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 120. FRANCE CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 121. FRANCE CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. FRANCE CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. FRANCE CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. FRANCE CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. FRANCE CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. FRANCE CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. RUSSIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 128. RUSSIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 129. RUSSIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 130. RUSSIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 131. RUSSIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. RUSSIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. RUSSIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. RUSSIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. ITALY CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 136. ITALY CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 137. ITALY CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. ITALY CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. ITALY CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. ITALY CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. ITALY CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. ITALY CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. SPAIN CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 144. SPAIN CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 145. SPAIN CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 146. SPAIN CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 147. SPAIN CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. SPAIN CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. SPAIN CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. SPAIN CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 160. SAUDI ARABIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. SAUDI ARABIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. SAUDI ARABIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. SAUDI ARABIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 168. SOUTH AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. SOUTH AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. SOUTH AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. SOUTH AFRICA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. DENMARK CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 176. DENMARK CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 177. DENMARK CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. DENMARK CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. DENMARK CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. DENMARK CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. DENMARK CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. DENMARK CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. NETHERLANDS CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 184. NETHERLANDS CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 185. NETHERLANDS CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. NETHERLANDS CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. NETHERLANDS CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. NETHERLANDS CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. NETHERLANDS CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. NETHERLANDS CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. QATAR CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 192. QATAR CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 193. QATAR CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. QATAR CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. QATAR CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. QATAR CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. QATAR CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. QATAR CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. FINLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 200. FINLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 201. FINLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 202. FINLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 203. FINLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. FINLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. FINLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. FINLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. SWEDEN CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 208. SWEDEN CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 209. SWEDEN CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. SWEDEN CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. SWEDEN CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. SWEDEN CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. SWEDEN CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. SWEDEN CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. NIGERIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 216. NIGERIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 217. NIGERIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 218. NIGERIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 219. NIGERIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. NIGERIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. NIGERIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. NIGERIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. EGYPT CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 224. EGYPT CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 225. EGYPT CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. EGYPT CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. EGYPT CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. EGYPT CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. EGYPT CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. EGYPT CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. TURKEY CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 232. TURKEY CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 233. TURKEY CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. TURKEY CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. TURKEY CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. TURKEY CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. TURKEY CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. TURKEY CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. ISRAEL CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 240. ISRAEL CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 241. ISRAEL CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 242. ISRAEL CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 243. ISRAEL CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. ISRAEL CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. ISRAEL CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. ISRAEL CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. NORWAY CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 248. NORWAY CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 249. NORWAY CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. NORWAY CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. NORWAY CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. NORWAY CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. NORWAY CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. NORWAY CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. POLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 256. POLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 257. POLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 258. POLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 259. POLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. POLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. POLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. POLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. SWITZERLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 264. SWITZERLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 265. SWITZERLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. SWITZERLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. SWITZERLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. SWITZERLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. SWITZERLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. SWITZERLAND CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 272. ASIA-PACIFIC CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 274. ASIA-PACIFIC CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. ASIA-PACIFIC CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. ASIA-PACIFIC CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC CHRONIC REFRACTORY COUGH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 280. ASIA-PACIFIC CHRONIC REFRACTORY COUGH MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 281. CHINA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 282. CHINA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 283. CHINA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 284. CHINA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 285. CHINA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. CHINA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. CHINA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. CHINA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. INDIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 290. INDIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 291. INDIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 292. INDIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 293. INDIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. INDIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. INDIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. INDIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. JAPAN CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 298. JAPAN CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 299. JAPAN CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 300. JAPAN CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 301. JAPAN CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. JAPAN CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. JAPAN CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. JAPAN CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. AUSTRALIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 306. AUSTRALIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 307. AUSTRALIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 308. AUSTRALIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 309. AUSTRALIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. AUSTRALIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. AUSTRALIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. AUSTRALIA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. SOUTH KOREA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 314. SOUTH KOREA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 315. SOUTH KOREA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 316. SOUTH KOREA CHRONIC REFRACTORY COUGH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 317. SOUTH KOREA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. SOUTH KOREA CHRONIC REFRACTORY COUGH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. SOUTH KOREA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. SOUTH KOREA CHRONIC REFRACTORY COUGH MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321.

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Chronic Refractory Cough market report include:
  • Merck & Co., Inc.
  • Bayer AG
  • Bellus Health Inc.
  • Shionogi & Co., Ltd.
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.23 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.32 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Chronic Refractory Cough Drug Pipeline Analysis Report 2025 - Product Image

Chronic Refractory Cough Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Chronic Refractory Cough - Pipeline Insight, 2025 - Product Image

Chronic Refractory Cough - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Chronic Refractory Cough (CRC) Epidemiology Forecast 2025-2034 - Product Image

Chronic Refractory Cough (CRC) Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From
Cough In Idiopathic Pulmonary Fibrosis (IPF) - Pipeline Insight,2025 - Product Image

Cough In Idiopathic Pulmonary Fibrosis (IPF) - Pipeline Insight,2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Antitussive Drugs - Global Strategic Business Report - Product Image

Antitussive Drugs - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From

About the Chronic Refractory Cough Drugs Market

The Chronic Refractory Cough Drugs market is a subset of the larger Respiratory Drugs market. It is composed of drugs used to treat chronic refractory cough, a condition characterized by a persistent cough that does not respond to conventional treatments. These drugs are typically used in combination with other treatments, such as lifestyle modifications, to reduce the severity of the cough. Commonly used drugs include anticholinergics, antihistamines, and mucolytics. These drugs are used to reduce inflammation, reduce mucus production, and reduce airway irritation. The Chronic Refractory Cough Drugs market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, AstraZeneca, and Novartis. Other companies include Sanofi, Boehringer Ingelheim, and Sun Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.